CBG Biotech

When engineered solvents become harder to source, replacing them isn’t always simple.
Qualification timelines, process validation, and solvent loss can drive costs higher than expected.

More manufacturers are stepping back to reassess how solvents are managed across their lifecycle, not just what chemistry they use.

This breakdown explores why, and what’s changing.
https://hubs.ly/Q04g-vWf0

Solvent recycling usually isn’t the first thing labs think about. It typically becomes a priority as waste volume and disposal requirements start to build — and teams look for ways to reduce that burden and make better use of the solvents they already handle.

Get answers from more FAQs:
https://hubs.ly/Q04gZWKK0

Not all xylene substitutes behave the same way in histology and pathology workflows. Differences in drying time, solvency, residue and compatibility can affect consistency and throughput after a switch. If you’re evaluating alternatives, understanding those tradeoffs matters more than the SDS label.

👉Learn more: https://hubs.ly/Q04fhvxT0